“…26 The incidence of PTB in our patient cohort was much lower than expected, and although screening with chest X-rays (CXR) and sputum are performed routinely on every patient at the time of program enrollment, the low sensitivity and specificity of this type of screening is well known. 27,28 Potentially, more patients had undiagnosed PTB at ART initiation and were at higher risk of adverse outcomes than those who were actually diagnosed, perhaps because they were monitored less closely for other comorbidities such as the immune reconstitution inflammatory syndrome (IRIS) or were less likely to be receiving prophylactic co-trimoxazole.…”